Stock VEN VENTAS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Ventas, Inc. Deutsche Boerse AG

Equities

VEN

US92276F1003

Real-time Estimate Tradegate
Other stock markets
 10:26:21 2024-06-28 EDT 		5-day change 1st Jan Change
47.54 EUR +2.58% Intraday chart for Ventas, Inc. +1.63% +3.98%
06-21 Raymond James Adjusts Price Target on Ventas to $55 From $50.26 MT
06-20 BNP Paribas Exane Adjusts Price Target on Ventas to $59 From $54 MT

Evolution of the average Target Price on Ventas, Inc.

Price target over the last 5 years

History of analyst recommendation changes

cdc535ef4321a534ad52fd5a4bd.evkEXw6Zgs_uFs1VxC3s93owLZw41N_jWEhBQWpfwlw.LalWaTetsLa7eok3pkazzjVVa7F87OyBPxwnMBsqpjMjnGEdYc72upRE-Q~f4cb3af5291fcc8bd800b104ffa3d4c8

Analyst Recommendations on Ventas, Inc.

Raymond James Adjusts Price Target on Ventas to $55 From $50.26 MT
BNP Paribas Exane Adjusts Price Target on Ventas to $59 From $54 MT
Baird Adjusts Price Target on Ventas to $51 From $49 MT
BMO Capital Adjusts Price Target on Ventas to $57 From $53, Keeps Outperform Rating MT
Scotiabank Adjusts Price Target on Ventas to $52 From $51 MT
Evercore ISI Adjusts Price Target on Ventas to $53 From $51, Keeps Outperform Rating MT
Deutsche Bank Adjusts Ventas Price Target to $55 From $60, Maintains Buy Rating MT
Wells Fargo Adjusts Price Target on Ventas to $49 From $46 MT
JPMorgan Adjusts Price Target on Ventas to $50 From $48 MT
BMO Capital Adjusts Ventas Price Target to $53 From $51 MT
Scotiabank Adjusts Price Target on Ventas to $51 From $47 MT
Morgan Stanley Adjusts Price Target on Ventas to $49 From $47, Keeps Equalweight Rating MT
Ventas Insider Sold Shares Worth $697,653, According to a Recent SEC Filing MT
Jefferies Adjusts Price Target on Ventas to $56 From $52 MT
RBC Capital Adjusts Price Target on Ventas to $52 From $50 MT
ANALYST RECOMMENDATIONS : Nvidia, The Home Depot, Lowe's, Rollins... Our Logo
Evercore ISI Adjusts Ventas' Price Target to $51 From $50, Keeps Outperform Rating MT
Wedbush Raises Price Target on Ventas to $54 Form $52, Keeps Outperform Rating MT
Evercore ISI Adjusts Price Target on Ventas to $50 From $49 MT
Evercore ISI Adjusts Price Target on Ventas to $49 From $50 MT
Evercore ISI Upgrades Ventas to Outperform From In Line, Price Target is $50 MT
Wells Fargo Downgrades Ventas to Equalweight From Overweight, Adjusts Price Target to $46 From $52 MT
ANALYST RECOMMENDATIONS : AbbVie, Doordash, Eli Lilly, Moderna, Hiscox... Our Logo
BofA Upgrades Ventas to Buy From Neutral on External Growth Opportunities, Adjusts Price Target to $53 From $48 MT
Mizuho Adjusts Ventas' Price Target to $56 From $53, Maintains Buy Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
50.81 USD
Average target price
54.56 USD
Spread / Average Target
+7.37%
High Price Target
69 USD
Spread / Highest target
+35.80%
Low Price Target
49 USD
Spread / Lowest Target
-3.56%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Ventas, Inc.

Raymond James
BNP Paribas Exane
Baird
BMO Capital
Scotiabank
Evercore ISI
Deutsche Bank Securities
Wells Fargo Securities
JPMorgan Chase
Morgan Stanley
Jefferies & Co.
RBC Capital Markets
Wedbush
BofA Securities
Mizuho Securities
Barclays
Credit Suisse
SMBC Nikko
KeyBanc Capital Markets
Berenberg Bank
Citigroup
Wolfe Research

Ratings for Ventas, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. VTR Stock
  4. VEN Stock
  5. Consensus Ventas, Inc.